UNH vs DGX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | DGX |
|---|---|---|
| Price | $396.59 | $244.51 |
| Market cap | $355.98B | $26.99B |
| P/E ratio | 25.6 | 26.0 |
| ROE | 14.15% | 14.60% |
| Profit margin | 3.14% | 9.19% |
| Revenue growth | 0.40% | 10.20% |
| Dividend yield | 2.33% | 1.41% |
| Beta | 0.63 | 0.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs DGX in plain English
- UNH is the bigger company — about 13.2× the market cap of DGX.
- UNH is cheaper on earnings (P/E 25.6 vs 26.0).
- DGX earns a higher return on equity (15% vs 14%).
- DGX is growing revenue faster (10% vs 0%).
- UNH has the higher dividend yield (2.33% vs 1.41%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.